...
首页> 外文期刊>Journal of Medicinal Chemistry >Discovery of N1-(6-Chloroimidazo[2,1-b][1,3]-thiazole-5-sulfonyl)tryptamine as a Potent,Selective,and Orally Active 5-HT6 Receptor Agonist
【24h】

Discovery of N1-(6-Chloroimidazo[2,1-b][1,3]-thiazole-5-sulfonyl)tryptamine as a Potent,Selective,and Orally Active 5-HT6 Receptor Agonist

机译:发现N1-(6-氯咪唑并[2,1-b] [1,3]-噻唑-5-磺酰基)色胺为强效,选择性和口服活性的5-HT6受体激动剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

N1-Arylsulfonyltryptamines have been identified as 5-HT6 receptor ligands.In particular,N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine(11q)is a high affinity,potent full agonist(5-HT6 K_i=2 nM,EC50=6.5 nM,E_(max)=95.5%).Compound 11q is selective in a panel of over 40 receptors and ion channels,has good pharmacokinetic profile,has been shown to increase GABA levels in the rat frontal cortex,and is active in the schedule-induced polydipsia model for obsessive compulsive disorders.
机译:N1-芳基磺酰基色胺已被鉴定为5-HT6受体配体。特别是N1-(6-氯咪唑并[2,1-b] [1,3]噻唑-5-磺酰基)色胺(11q)具有高亲和力完全激动剂(5-HT6 K_i = 2 nM,EC50 = 6.5 nM,E_(max)= 95.5%)。化合物11q在40多种受体和离子通道中具有选择性,具有良好的药代动力学特征,并显示出增加的作用GABA在大鼠额叶皮层中的水平,并在强迫症的日程诱发的多饮症模型中活跃。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号